Volume 10, Number 9—September 2004
Dispatch
Barriers to Creutzfeldt-Jakob Disease Autopsies, California
Table 1
Characteristic | Neurologists n/N (%) | Pathologists n/N (%) | Neuropathologists n/N (%) |
---|---|---|---|
Have evaluated a case of CJD | 212/310 (68) | 56/259 (22) | 18/33 (55) |
Median no. (range) of CJD cases evaluated | 3 (0–30) | 2 (0–30) | 10 (0–50) |
Type of practice | |||
Private practice/private hospital | 144/308 (47) | 122/278 (44) | 8/33 (25) |
Outpatient HMOa/managed care | 55/308 (18) | – | – |
Community hospital/clinic | 1/308 (<1) | 68/278 (24) | 4/33 (12) |
University affiliated | 82/308 (27) | 37/278 (13) | 10/33 (30) |
Veterans hospital | 13/308 (4) | 3/278 (1) | 1/33 (3) |
County medical examiner or coroner | – | 7/278 (3) | 2/33 (6) |
Other | 15/308 (5) | 41/278 (15) | 5/33 (15) |
Can recognize the clinical or pathologic features of classic CJD | 255/307 (83) | 96/273 (35) | 25/28 (89) |
Can recognize the clinical or pathologic features of variant CJD | 120/305 (39) | 40/274 (15) | 18/28 (64) |
Have not considered arranging for an autopsy for CJD patients under their care | 74/207 (36) | – | – |
Pathology group available at facility to perform autopsy on suspect CJD cases | 223/297 (75) | 74/259 (29) | 17/28 (61) |
Pathology group available at facility to confirm diagnosis of suspect CJD with histopathologic analysis | 223/297 (75) | 91/254 (36) | 18/27 (67) |
aHMO, health maintenance organization.
Page created: March 29, 2011
Page updated: March 29, 2011
Page reviewed: March 29, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.